Error: Could not add to watchlist. X
+ Watchlist

Miragen Therapeutics Inc

MGEN:US
NASDAQ CM
7.880
USD
0.470
5.63%
As of 8:10 PM EDT 6/22/2017
Open
8.360
Day Range
7.388 - 8.630
Volume
103,815
Previous Close
8.350
52Wk Range
1.800 - 18.000
1 Yr Return
9.90%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
8.360
Day Range
7.388 - 8.630
Volume
103,815
Previous Close
8.350
52Wk Range
1.800 - 18.000
1 Yr Return
9.90%
YTD Return
57.29%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-16.798
Market Cap (m USD)
168.687
Shares Outstanding (m)
21.407
Price/Sales (TTM)
1.70
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.05%
% Price Change
+1.26%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Miragen Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops microRNA biology, oligonucleotide chemistry, drugs, and therapies for cancer, pathologic fibrosis, neuro-inflammatory, and cardiovascular diseases. Miragen Therapeutics serves customers in the United States.
Address
5740 Fleet Street
Carlsbad, CA 92008
United States
Phone
1-760-537-4100
  • William S Marshall
    President/CEO
  • Jason A Leverone
    CFO/Treasurer/Secretary
  • Adam S Levy
    Chief Business Officer
  • Paul D Rubin
    Exec VP:Research & Dev
Show More